| ²é¿´: 269 | »Ø¸´: 4 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷ÕßhuigenghaoÔö¼Ó½ð±Ò 1 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
huigenghaoÖÁ×ðľ³æ (ÖøÃûдÊÖ)
|
[×ÊÔ´]
ÈËÓô¦·½Ò©ºÍÉúÎïÖÆÆ·±êÇ©Ó÷¨ÓÃÁ¿µÄÄÚÈݺ͸ñʽ--FDAÖ¸ÄÏ
|
|
|
Guidance for Industry Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products ¡ªContent and Format DRAFT GUIDANCE ÊÇFDA2007.04гöµÄÖ¸ÄÏ ´ó¼ÒѧϰһÏ£¡ |
» ²ÂÄãϲ»¶
¸ßθßѹ·´Ó¦ÇóÖú
ÒѾÓÐ4È˻ظ´
ÖÆÒ©¹¤³ÌרҵÕÐÊÕµ÷¼Á£¬ÒªÇó¹ý¹ú¼ÒÏß
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ266È˻ظ´
ÎåÒØ´óѧҩÎﻯѧÉúÎïѧÍŶÓ-ÀîÀ¼Çå¿ÎÌâ×éÕÐÊÕµ÷¼ÁѧÉú
ÒѾÓÐ0È˻ظ´
ҩѧBÇøÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ1È˻ظ´
ÖØÇìÒ½¿Æ´óѧ-È˹¤ÖÇÄÜҽѧѧԺ
ÒѾÓÐ0È˻ظ´
ÖØÇìÒ½¿Æ´óѧ-È˹¤ÖÇÄÜҽѧѧԺ
ÒѾÓÐ0È˻ظ´
342Ò»Ö¾Ô¸´ó¹¤ÖÆÒ©×¨Ë¶£¬±¾¿Æ211£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´














»Ø¸´´ËÂ¥